12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cinryze regulatory update

The All Wales Medicines Strategy Group (AWMSG) recommended the use of Cinryze from ViroPharma on the National Health Service (NHS) in Wales for its approved indications - routine prevention,...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >